Review




Structured Review

Charles River Laboratories mhcii deficient
Mhcii Deficient, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/deficient+mhcii/bio_rxiv__64898__2026__05__04__722795-237-3-24
Average 86 stars, based on 1 article reviews
mhcii deficient - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

other:

Article Title: Type 2 conventional dendritic cells and regulatory T cells form a barrier tissue circuit to control allergic inflammation
Article Snippet: C57BL/6J, CD45.1 CRL, MHCII-deficient (B6.129S2- H2 dlAb1-Ea /J, stock no. 003584) and Thy1.1 (B6.PL- Thy1 a /CyJ, stock no. 000406) mice were purchased from Charles River Laboratories (Wilmington, MA) or the Jackson Laboratory (Bar Harbor, ME).



Similar Products

86
Charles River Laboratories mhcii deficient
Mhcii Deficient, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/deficient+mhcii/bio_rxiv__64898__2026__05__04__722795-237-3-24
Average 86 stars, based on 1 article reviews
mhcii deficient - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Jackson Laboratory mhcii-deficient c57bl/6 mice
Mhcii Deficient C57bl/6 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/c57bl+6j+mice/pmc10948025-335-20-36
Average 90 stars, based on 1 article reviews
mhcii-deficient c57bl/6 mice - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Jackson Laboratory mhcii-deficient c57bl/6 mice stock no. 003584
Mhcii Deficient C57bl/6 Mice Stock No. 003584, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/c57bl+6j+mice/pm37587342-472-18-35
Average 90 stars, based on 1 article reviews
mhcii-deficient c57bl/6 mice stock no. 003584 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Jackson Laboratory mhc class ii deficient mhcii mice
Mhc Class Ii Deficient Mhcii Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/mice+ob+ob/pm33312179-49-5-14
Average 86 stars, based on 1 article reviews
mhc class ii deficient mhcii mice - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Jackson Laboratory mhcii deficient (homozygous h2 dlab1-ea)
cDCs set the circulating concentration of sIL-6R, and this regulates antibody responses (A) Histograms reporting surface IL-6R in immune cells from WT, cDC- Irf5 −/− , and cDC- IL6ra −/− mice (B cells = B220 + /CD3 − , T cells = CD3 + /B220 − , cDCs = CD3 − /B220 − <t>/MHCII</t> + /CD11c hi , tissue resident macrophages = CD3 − /B220 − /CD11b + /F4-80 + ). Quantification of these data is presented as the proportion of cells expressing surface IL-6R (mean ± SD, n = 3 per group, ∗∗∗ p < 0.001, ANOVA with Tukey’s test). (B) Total IRF5 was measured in cDCs (B220 − /CD3 − /CD11c hi /MHCII + ) isolated by fluorescence-activated cell sorting (FACS) on splenocytes of WT and cDC- Irf5 −/− animals. The sorted cDCs (200,000 cells) were lysed, separated by SDS-PAGE, and immunoblotted for either IRF5 or β-actin. (C) Serum IgM versus IgG responses against HA (with lipid A adjuvant) in transgenic mice (mean ± SD, n = 4 animals per group). The dilution curves were quantified by endpoint dilution; ∗∗ p < 0.01, ANOVA with Tukey’s test. (D) Serum sIL-6R as measured in WT, cDC- Irf5 −/− , and cDC- IL6ra −/− (mean ± SD, n = 4 animals per group); ∗∗∗∗ p < 0.0001, ANOVA with Tukey’s test. (E) Co-injection of recombinant murine sIL-6R rescued the IgM and IgG responses to HA (with lipid A adjuvant) in cDC- IL6ra −/− animals (mean ± SD, n = 4 animals per group). The dilution curves were quantified by endpoint dilution; ∗∗ p < 0.01, ANOVA with Tukey’s test. See also and for immune cell subsets in cDC- IL6ra −/− and cDC- IL6ra −/− , sIL6R concentration <t>in</t> <t>cDC-DTR,</t> and IL6R expression by cDC1 and cDC2 in cDC- IL6ra −/− and Batf3 −/− .
Mhcii Deficient (Homozygous H2 Dlab1 Ea), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/mhcii+++++mice/pmc07836640-230-16-6
Average 90 stars, based on 1 article reviews
mhcii deficient (homozygous h2 dlab1-ea) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Jackson Laboratory mouse: mhcii deficient ( h2 dlab1-ea)

Mouse: Mhcii Deficient ( H2 Dlab1 Ea), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/b6+129s2++ighm+tm1cgn++j+mice/pmc07836640-63-0-8
Average 90 stars, based on 1 article reviews
mouse: mhcii deficient ( h2 dlab1-ea) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Jackson Laboratory mhcii-deficient b6.129s2- h2 dlab1-ea /j

Mhcii Deficient B6.129s2 H2 Dlab1 Ea /J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/b6+129s2++ighm+tm1cgn++j+mice/pmc06301113-472-0-27
Average 90 stars, based on 1 article reviews
mhcii-deficient b6.129s2- h2 dlab1-ea /j - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Jackson Laboratory spf c57bl/6, rag1 −/− , icosl −/− and h2-ab1 −/− (mhcii-deficient) mice

Spf C57bl/6, Rag1 −/− , Icosl −/− And H2 Ab1 −/− (Mhcii Deficient) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/rag1+++++mice/pmc06531000-184-11-15
Average 90 stars, based on 1 article reviews
spf c57bl/6, rag1 −/− , icosl −/− and h2-ab1 −/− (mhcii-deficient) mice - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Jackson Laboratory mhcii-deficient mice

Mhcii Deficient Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/c57bl+6j+mice/pmc05806123-135-5-12
Average 90 stars, based on 1 article reviews
mhcii-deficient mice - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Inserm Transfert major histocompatibility class ii mhcii deficiency

Major Histocompatibility Class Ii Mhcii Deficiency, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mhcii+deficient/class+deficiency+histocompatibility+ii+major+mhcii/pm28963631-82-65-33
Average 86 stars, based on 1 article reviews
major histocompatibility class ii mhcii deficiency - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


cDCs set the circulating concentration of sIL-6R, and this regulates antibody responses (A) Histograms reporting surface IL-6R in immune cells from WT, cDC- Irf5 −/− , and cDC- IL6ra −/− mice (B cells = B220 + /CD3 − , T cells = CD3 + /B220 − , cDCs = CD3 − /B220 − /MHCII + /CD11c hi , tissue resident macrophages = CD3 − /B220 − /CD11b + /F4-80 + ). Quantification of these data is presented as the proportion of cells expressing surface IL-6R (mean ± SD, n = 3 per group, ∗∗∗ p < 0.001, ANOVA with Tukey’s test). (B) Total IRF5 was measured in cDCs (B220 − /CD3 − /CD11c hi /MHCII + ) isolated by fluorescence-activated cell sorting (FACS) on splenocytes of WT and cDC- Irf5 −/− animals. The sorted cDCs (200,000 cells) were lysed, separated by SDS-PAGE, and immunoblotted for either IRF5 or β-actin. (C) Serum IgM versus IgG responses against HA (with lipid A adjuvant) in transgenic mice (mean ± SD, n = 4 animals per group). The dilution curves were quantified by endpoint dilution; ∗∗ p < 0.01, ANOVA with Tukey’s test. (D) Serum sIL-6R as measured in WT, cDC- Irf5 −/− , and cDC- IL6ra −/− (mean ± SD, n = 4 animals per group); ∗∗∗∗ p < 0.0001, ANOVA with Tukey’s test. (E) Co-injection of recombinant murine sIL-6R rescued the IgM and IgG responses to HA (with lipid A adjuvant) in cDC- IL6ra −/− animals (mean ± SD, n = 4 animals per group). The dilution curves were quantified by endpoint dilution; ∗∗ p < 0.01, ANOVA with Tukey’s test. See also and for immune cell subsets in cDC- IL6ra −/− and cDC- IL6ra −/− , sIL6R concentration in cDC-DTR, and IL6R expression by cDC1 and cDC2 in cDC- IL6ra −/− and Batf3 −/− .

Journal: Immunity

Article Title: The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells

doi: 10.1016/j.immuni.2020.12.001

Figure Lengend Snippet: cDCs set the circulating concentration of sIL-6R, and this regulates antibody responses (A) Histograms reporting surface IL-6R in immune cells from WT, cDC- Irf5 −/− , and cDC- IL6ra −/− mice (B cells = B220 + /CD3 − , T cells = CD3 + /B220 − , cDCs = CD3 − /B220 − /MHCII + /CD11c hi , tissue resident macrophages = CD3 − /B220 − /CD11b + /F4-80 + ). Quantification of these data is presented as the proportion of cells expressing surface IL-6R (mean ± SD, n = 3 per group, ∗∗∗ p < 0.001, ANOVA with Tukey’s test). (B) Total IRF5 was measured in cDCs (B220 − /CD3 − /CD11c hi /MHCII + ) isolated by fluorescence-activated cell sorting (FACS) on splenocytes of WT and cDC- Irf5 −/− animals. The sorted cDCs (200,000 cells) were lysed, separated by SDS-PAGE, and immunoblotted for either IRF5 or β-actin. (C) Serum IgM versus IgG responses against HA (with lipid A adjuvant) in transgenic mice (mean ± SD, n = 4 animals per group). The dilution curves were quantified by endpoint dilution; ∗∗ p < 0.01, ANOVA with Tukey’s test. (D) Serum sIL-6R as measured in WT, cDC- Irf5 −/− , and cDC- IL6ra −/− (mean ± SD, n = 4 animals per group); ∗∗∗∗ p < 0.0001, ANOVA with Tukey’s test. (E) Co-injection of recombinant murine sIL-6R rescued the IgM and IgG responses to HA (with lipid A adjuvant) in cDC- IL6ra −/− animals (mean ± SD, n = 4 animals per group). The dilution curves were quantified by endpoint dilution; ∗∗ p < 0.01, ANOVA with Tukey’s test. See also and for immune cell subsets in cDC- IL6ra −/− and cDC- IL6ra −/− , sIL6R concentration in cDC-DTR, and IL6R expression by cDC1 and cDC2 in cDC- IL6ra −/− and Batf3 −/− .

Article Snippet: The following mice were purchased from Jackson Laboratories: C57BL/6, Tcra −/− , Zbtb46 -DTR +/+ , MHCII deficient (homozygous H2 dlAb1-Ea ), Il6 −/− , Il12p40 −/− , Zbtb46 - cre +/+ , Il6ra flox/flox , Irf5 flox/flox , Adam17 flox/flox , Batf3 −/− , Tlr4 −/− , Tlr7 −/− and Ifnar1 −/− .

Techniques: Concentration Assay, Expressing, Isolation, Fluorescence, FACS, SDS Page, Adjuvant, Transgenic Assay, Injection, Recombinant

cDC-derived sIL-6R gates antibody responses by controlling plasma cell differentiation (A) Surface expression of gp130 on B cells (B220 + /CD3 − , gate I) versus plasmablasts (CD3 − /B220 lo /CD138 + , gate II) isolated from spleen of WT mice. The splenocytes were either left unstimulated or exposed to sIL-6Rα or IL6-sIL-6Rα (hyper-IL-6). (B) Same as in (A), except that animals were first immunized with lipid A adjuvant and spleen was harvested 3 days later. (C) Quantification of the data in (A). Signaling induced within gate I and gate II was measured as the percentage of STAT3-activated cells (sIL-6Rα-stimulated minus unstimulated and IL-6-sIL-6Rα-stimulated minus unstimulated; mean ± SD, n = 4 animals per group, ∗∗∗ p < 0.001, Student’s t test). (D) Quantification of the data in (B) (as in C). (E) Differentiation from plasmablasts (CD3 − /B220 lo /CD138 + /MHCII + ) to plasma cells (CD3 − /B220 lo /CD138 + /MHC class II lo /CD93 + ) was monitored within each genotype 1 week post-immunization with lipid A adjuvant, and cDC- IL6ra −/− mice were also co-injected with recombinant sIL-6R (as in <xref ref-type=Figure 2 E). The proportion of plasmablasts differentiating into plasma cells (indicated by a box in flow plots) was then quantified below (mean ± SD, n = 3 animals per group; ∗∗ p < 0.005, ANOVA with Tukey’s test). (F) Model for T cell-independent, cDC-dependent control over antibody responses. " width="100%" height="100%">

Journal: Immunity

Article Title: The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells

doi: 10.1016/j.immuni.2020.12.001

Figure Lengend Snippet: cDC-derived sIL-6R gates antibody responses by controlling plasma cell differentiation (A) Surface expression of gp130 on B cells (B220 + /CD3 − , gate I) versus plasmablasts (CD3 − /B220 lo /CD138 + , gate II) isolated from spleen of WT mice. The splenocytes were either left unstimulated or exposed to sIL-6Rα or IL6-sIL-6Rα (hyper-IL-6). (B) Same as in (A), except that animals were first immunized with lipid A adjuvant and spleen was harvested 3 days later. (C) Quantification of the data in (A). Signaling induced within gate I and gate II was measured as the percentage of STAT3-activated cells (sIL-6Rα-stimulated minus unstimulated and IL-6-sIL-6Rα-stimulated minus unstimulated; mean ± SD, n = 4 animals per group, ∗∗∗ p < 0.001, Student’s t test). (D) Quantification of the data in (B) (as in C). (E) Differentiation from plasmablasts (CD3 − /B220 lo /CD138 + /MHCII + ) to plasma cells (CD3 − /B220 lo /CD138 + /MHC class II lo /CD93 + ) was monitored within each genotype 1 week post-immunization with lipid A adjuvant, and cDC- IL6ra −/− mice were also co-injected with recombinant sIL-6R (as in Figure 2 E). The proportion of plasmablasts differentiating into plasma cells (indicated by a box in flow plots) was then quantified below (mean ± SD, n = 3 animals per group; ∗∗ p < 0.005, ANOVA with Tukey’s test). (F) Model for T cell-independent, cDC-dependent control over antibody responses.

Article Snippet: The following mice were purchased from Jackson Laboratories: C57BL/6, Tcra −/− , Zbtb46 -DTR +/+ , MHCII deficient (homozygous H2 dlAb1-Ea ), Il6 −/− , Il12p40 −/− , Zbtb46 - cre +/+ , Il6ra flox/flox , Irf5 flox/flox , Adam17 flox/flox , Batf3 −/− , Tlr4 −/− , Tlr7 −/− and Ifnar1 −/− .

Techniques: Derivative Assay, Clinical Proteomics, Cell Differentiation, Expressing, Isolation, Adjuvant, Injection, Recombinant, Control

Journal: Immunity

Article Title: The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells

doi: 10.1016/j.immuni.2020.12.001

Figure Lengend Snippet:

Article Snippet: The following mice were purchased from Jackson Laboratories: C57BL/6, Tcra −/− , Zbtb46 -DTR +/+ , MHCII deficient (homozygous H2 dlAb1-Ea ), Il6 −/− , Il12p40 −/− , Zbtb46 - cre +/+ , Il6ra flox/flox , Irf5 flox/flox , Adam17 flox/flox , Batf3 −/− , Tlr4 −/− , Tlr7 −/− and Ifnar1 −/− .

Techniques: Virus, Recombinant, Staining, Adjuvant, Lysis, Blocking Assay, Produced, Enzyme-linked Immunosorbent Assay, Software

Journal: Immunity

Article Title: The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells

doi: 10.1016/j.immuni.2020.12.001

Figure Lengend Snippet:

Article Snippet: Mouse: MHCII deficient ( H2 dlAb1-Ea ) , Jackson laboratory , Stock no. 003584.

Techniques: Virus, Recombinant, Staining, Adjuvant, Lysis, Blocking Assay, Produced, Enzyme-linked Immunosorbent Assay, Software